Pharmacologic IRE1 Activation Rewires Cholesterol Metabolism to Suppress T H 17 Differentiation
Year: 2026
Type: preprint
Abstract: T helper 17 (T H 17) cells are a subset of CD4⁺ T cells that coordinate immune responses against extracellular bacterial and fungal pathogens. Dysregulation of T H 17 cell responses drives excessive inflammation and contributes to the development of chronic inflammatory and autoimmune diseases, including psoriasis, inflammatory bowel disease, and multiple sclerosis. Here, we demonstrate that pharmacologic activation of the IRE1 signaling arm of the unfolded protein response (UPR) selectively reduces differentiation of T H 17 cells without impacting the differentiation of other helper T cell subsets. We show that IRE1 activation suppresses T H 17 differentiation by limiting intracellular cholesterol in differentiating T H 17 cells through the increased degradation of the rate-limiting cholesterol biosynthesis enzyme HMGCR. Our findings identify IRE1 as a metabolic checkpoint regulating cholesterol biosynthesis in differentiating T H 17 cells and demonstrate that its pharmacological activation suppresses T H 17 differentiation, highlighting a potential therapeutic strategy for limiting T H 17-driven inflammatory diseases.
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
Award: G9000185148
OpenAlex ID: W7234344290
